Tissue Engineering And Nanotheranostics

b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

260 Tissue Engineering and Nanotheranostics

74. Yu H, Tang Z, Zhang D, Song W, Zhang Y, Yang Y, Ahmad Z, Chen
    X. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin
    loaded poly(L­glutamic acid)­g­methoxy poly(ethylene glycol) com­
    plex nanoparticles for tumor therapy. J. Control. Release 205 , 89–97
    (2015).


75. Arami H, Khandhar A, Liggitt D, Krishnan KM. In vivo delivery, phar­
    macokinetics, biodistribution and toxicity of iron oxide nanoparticles.
    Chem. Soc. Rev. 44 , 8576–8607 (2015).


76. Perez­Campana C, Gomez­Vallejo V, Puigivila M, Martin A. Calvo­
    Fernandez T, Moya SE, Ziolo RF, Reese T, Llop J. Biodistribution of
    different sized nanoparticles assessed by positron emission tomogra­
    phy: A general strategy for direct activation of metal oxide particles.
    ACS Nano. 7 , 3498–3505 (2013).


77. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines.
    J. Control. Release 145 , 182–195 (2010).


78. Elkhodiry MA, Momah CC, Suwaidi SR, Gadalla D, Martins AM,
    Vitor RF, Husseini GA. Synergistic nanomedicine: Passive, active, and
    ultrasound­triggered drug delivery in cancer treatment. J. Nanosci.
    Nanotechnol. 16 , 1–18 (2016).


79. Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME,
    DeSimone JM. The effect of particle design on cellular internalization
    pathways. Proc. Nat. Acad. Sci. USA. 105 , 11613–11618 (2008).


80. Wang J, Byrne JD, Napier ME, DeSimone JM. More effective nano­
    medicines through particle design. Small 7 , 1919–1931 (2011).


81. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi
    MG, Frangioni JV. Renal clearance of quantum dots. Nat. Biotechnol.
    25 , 1165–1170 (2007).


82. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nano­
    particles: critical issues in pharmacokinetics, opsonization and protein­
    binding properties. Prog. Lipid. Res. 42 , 463–478 (2003).


83. Kamaly N, Xiao Z, Valencia PM, Radovic­Moreno AF, Farokhzad OC.
    Targeted polymeric therapeutic nanoparticles: Design, development
    and clinical translation. Chem. Soc. Rev. 41 , 2971–3010 (2012).


84. Wang Q, Sun Y, Zhang Z, Duan Y. Targeted polymeric therapeutic
    nanoparticles: Design and interactions with hepatocellular carcinoma.
    Biomaterials 56 , 229–240 (2015).


85. Toy R, Peiris PM, Ghaghada KB, Karathanasis E. Shaping cancer nano­
    medicine: The effect of particle shape on the in vivo journey of nano­
    particles. Nanomedicine 9 , 121–134 (2014).